Citizen News Service (CNS), with support from the Lilly MDR-TB Partnership, recently released a report examining how drug-resistant tuberculosis (TB) in India is managed. The report covers lessons learned from selected sites in six cities across the country, and makes recommendations for improvements.

Novartis and a humanitarian organisation called Malaria No More are reported to have pledged to end death due to malaria in African countries through their campaign ‘Power of One’ by 2015. Novartis would support the campaign by donating three million tablets of malaria medicine Coartem, which would take the company’s total contribution to 200 million malaria treatments since 2009.

A new training centre has been set up by the United States Pharmacopeial Convention to tackle the pervasive problem of counterfeit medicines in Africa. The Center for Pharmaceutical Advancement and Training, based in Accra, Ghana, will train medicine regulatory officers, and provide expertise and develop talent so that African nations can better regulate drugs.

Hashtag:
#IndiaHealth

Global Health Progress is proud to host an hour-long, live conversation focused on health and health care in India with Professor David Taylor, co-author of the new UCL School of Pharmacy report 'Health and Health Care in India: national opportunities, global impacts'.  Joining the discussion on July 25th at 2:00 pm BST (9am EST or 6:30pm IST) will be Ratna Devi, CEO of DakshamA Health & Education and a member of Global Health Progress' expert advisory group.

On July 25th at 2:00 pm BST (9am EST or 6:30pm IST), Global Health Progress will host a live conversation focused on health and health care in India with Professor David Taylor, co-author of the new UCL School of Pharmacy report 'Health and Health Care in India: national opportunities, global impacts'. Joining the discussion will be Ratna Devi, CEO of DakshamA Health & Education and a member of Global Health Progress' expert advisory group.

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is partnering with the International Telecommunication Union (ITU) on Be Healthy, Be Mobile, an initiative led jointly by the ITU and WHO. With non-communicable diseases (NCDs) responsible for over 60% of worldwide deaths and growing quickly in the developing world, Be Healthy, Be Mobile will leverage mHealth technologies for the prevention and control of NCDs. A partner in global health, IFPMA will cooperate by sharing knowledge and resources, lessons learned, and technical expertise to help develop effective mHealth interventions for NCDs.

Today national and international leaders from more than 25 countries across Africa are meeting, at the 12th annual National Malaria Control Program (NMCP) Best Practice Sharing Workshop, to discuss the problem of sub-standard antimalarials in Africa and address key topics and challenges faced by the malaria community. Novartis, with support from leading international organizations, including the Global Fund, Clinton Health Access Initiative, ACTwatch, the Foundation for Innovative New Diagnostics, and the Global Business Coalition, has developed a workshop program to address and explore these issues and increase efforts to combat malaria.

The current world population of 7.2 billion is projected to increase by 1 million over the next 12 years and reach 9.6 billion by 2050, according to a United Nations report launched today, which points out that growth will be mainly in developing countries, with more than half in Africa. The report, World Population Prospects: the 2012 Revision, notes that the population of developed regions will remain largely unchanged at around 1.3 billion from now until 2050. In contrast, the 49 least developed countries are projected to double in size from around 900 million people in 2013 to 1.8 billion in 2050.

On 30 October 2013, patients in countries across Africa will come together to mark the first ever regional Patient Solidarity Day. They will call on all Ministers of Health and all healthcare stakeholders to “Improve lives through patient-centred healthcare.”

#PSD2013

The world's first vaccine against a strain of enterovirus has now been developed by Chinese researchers. The enterovirus that can cause hand, foot and mouth disease, especially in small children can also lead to deadly infections of the brain and spinal cord membranes.

Pages